High molecular weight form insulin-like growth factor II-producing mesenteric sarcoma causing hypoglycemia

Internal Medicine

Volumn 43, Issue 10, 2004, Pages 967-971

  Sato, Ryuji ^d   Tsujino, Motoyoshi ^d   Nishida, Kenji ^d   Otani, Yasukazu ^d   Minami, Tomohito ^d   Shichiri, Masayoshi ^a   Hizuka, Naomi ^b   Aiba, Motohiko ^c   Hitara, Yukio ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^c TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^d TOKYO METROPOLITAN TAMA MEDICAL CENTER   (Japan)

Author keywords

Hypoglycemia; Insulin like growth factor (IGF) II; Mesenteric sarcoma; Non islet cell tumor hypoglycemia (NICTH)

Indexed keywords

INSULIN; MESSENGER RNA; SOMATOMEDIN B;

AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; COLON RESECTION; FEMALE; FREQUENCY ANALYSIS; GENE EXPRESSION; HUMAN; HUMAN TISSUE; HYPOGLYCEMIA; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INSULIN BLOOD LEVEL; MESENTERY; MOLECULAR WEIGHT; POSTOPERATIVE COMPLICATION; PROTEIN BLOOD LEVEL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGMOID; SPINDLE CELL SARCOMA; TUMOR CELL; TUMOR LOCALIZATION;

AGED; AGED, 80 AND OVER; FEMALE; HUMANS; HYPOGLYCEMIA; IMMUNOHISTOCHEMISTRY; INSULIN-LIKE GROWTH FACTOR II; MESENTERY; MOLECULAR WEIGHT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SARCOMA; SIGMOID NEOPLASMS;

EID: 8844262999     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.43.967     Document Type: Article

References (20)

1. Marks V, Teale JD. Tumours producing hypoglycaemia. Diabetes Metab Rev 7: 79-91, 1991.
2. Werner H, LeRoith D. The role of the insulin-like growth factor system in human cancer. Adv Cancer Res 68: 183-223, 1996.
3. Daughaday WH, Trivedi B, Kapadia M. Measurement of insulin-like growth factor II by a specific radioreceptor assay in serum of normal individuals, patients with abnormal growth hormone secretion, and patients with tumor-associated hypoglycemia. J Clin Endocrinol Metab 53: 289-294, 1981.
4. Daughaday WH, Kapadia M. Significance of abnormal serum binding of insulin-like growth factor II in the development of hypoglycemia in patients with non-islet-cell tumors. Proc Natl Acad Sci USA 86: 6778-6782, 1989.
5. Shapiro ET, Bell GI, Polonsky KS, Rubenstein AH, Kew MC, Tager HS. Tumor hypoglycemia: relationship to high molecular weight insulin-like growth factor-II. J Clin Invest 85: 1672-1679, 1990.
6. Zapf J, Futo E, Peter M, Froesch ER. Can "big" insulin-like growth factor II in serum of tumor patients account for the development of extrapancreatic tumor hypoglycemia? J Clin Invest 90: 2574-2584, 1992.
7. Hizuka N, Fukuda I, Takano K, Okubo Y, Asakawa-Yasumoto K, Demura H. Serum insulin-like growth factor II in 44 patients with non-islet cell tumor hypoglycemia. Endocr J 45 (Suppl): S61-65, 1998.
8. Daughaday WH, Emanuele MA, Brooks MH, Barbato AL, Kapadia M, Rotwein P. Synthesis and secretion of insulin-like growth factor II by a leiomyosarcoma with associated hypoglycemia. N Engl J Med 319: 1434-1440, 1988.
9. Miyakawa M, Hizuka N, Takano K, et al. Radioimmunoassay for insulin-like growth factor I (IGF-I) using biosynthetic IGF-I. Endocrinol Jpn 33: 795-801, 1986.
10. Asakawa K, Hizuka N, Takano K, et al. Radioimmunoassay for insulin-like growth factor II (IGF-II). Endocrinol Jpn 37: 607-614, 1990.
11. Yamaguchi M, Kamimura S, Takada J, et al. Case report :Insulin-like growth factor II expression in hepatocellular carcinoma with alcoholic liver fibrosis accompanied by hypoglycaemia. J Gastroenterol Hepatol 13: 47-51, 1998.
12. D'Ercole AJ. Insulin-like growth factors and their receptors in growth. Endocrinol Metab Clin North Am 25: 573-590, 1996.
13. Lee JE, Pintar J, Efstratiadis A. Pattern of the insulin-like growth factor II gene expression during early mouse embryogenesis. Development 110: 151-159, 1990.
14. Morali OG, Jouneau A, McLaughlin KJ, Thiery JP, Larne L. IGF-II promotes mesoderm formation. Dev Biol 227: 133-145, 2000.
15. Han VK, D'Ercole AJ, Lund PK. Cellular localization of somatomedin (insulin-like growth factor) messenger RNA in the human fetus. Science 236: 193-197, 1987.
16. Baxter RC, Daughaday WH. Impaired formation of the ternary insulin-like growth factor-binding protein complex in patients with hypoglycemia due to nonislet cell tumors. J Clin Endocrinol Metab 73 696-702, 1991.
17. Chung J, Henry RR. Mechanisms of tumor-induced hypoglycemia with intraabdominal hemangiopericytoma. J Clin Endocrinol Metab 81: 919-925, 1996.
18. Ron D, Powers AC, Pandian MR, Godine JE, Axelrod L. Increased insulin-like growth factor II production and consequent suppression of growth hormone secretion: a dual mechanism for tumor-induced hypoglycemia. J Clin Endocrinol Metab 68: 701-706, 1989.
19. Fehmann HC, Jehle P, Markus U, Goke B. Functional active receptors for insulin-like growth factors-I (IGF-I) and IGF-II on insulin-, glucagon-, and somatostatin-producing cells. Metabolism 45 759-766, 1996.
20. Chung J, Henry RR. Mechanisms of tumor-induced hypoglycemia with intraabdominal hemangiopericytoma. J Clin Endocrinol Metab 81: 919-925, 1996.